I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)
0
follower
9
more
presentations
in this session
Does a clinical scientist led cardio-oncology clinic improve surveillance for cardio-toxicity for patients receiving trastuzumab compared to oncology services alone?